Global Health Partner AB (”GHP” or the “Company”) – a Swedish healthcare company operating specialised clinics in Sweden and UK – has applied to list on the OMX Nordic Exchange Stockholm.
Since its foundation in 2006, GHP has undertaken an extensive acquisition and growth strategy and established clinics in the areas of spine surgery, dental implant surgery, bariatric surgery and obesity treatment, and orthopaedic surgery and sports-medicine. GHP has the ambition to take the delivery of healthcare service beyond the standards and expectations created by the first generation of European-based private healthcare providers and to continue its growth strategy.
In order to facilitate GHP’s continued development and growth, and to fulfil OMX Nordic Exchange Stockholm’s ownership distribution requirements, the Board and the company’s shareholders have resolved to broaden the shareholder base by a new issue of shares. The Company Committee of the OMX Nordic Exchange Stockholm has decided to approve GHP for listing provided that the distribution requirement is met.
• The Offer comprises a total of 5 300 000 newly issued shares in GHP, corresponding to 8.2% of the total post-offering shares and votes in the Company, assuming full acceptance of the Offer
• Subscription price SEK 14.0 – 15.0 per share
• Application period for customers of SEB Retail Banking and Avanza September 22 – October 1, 2008
• Expected first day of trading is October 3, 2008 on the OMX Nordic Exchange Stockholm, Small Cap, Health Care
“A listing of GHP on the OMX Nordic Exchange Stockholm has been under consideration for a long time and we believe it will bring several advantages to GHP. The majority of our current operations are carried out in Scandinavia and our corporate headquarters and senior management are based in Gothenburg. In addition, the perceived appetite for GHP shares, among both institutions and private investors, and the access to the capital markets in Sweden are improved by this listing”, says Per Båtelson, CEO and Co-Founder of GHP.
”GHP has demonstrated a strong development since its foundation in 2006. Subsequent to achieving a listing on the OMX Nordic Exchange Stockholm, and completing the equity issue and the broadening of the shareholder base realized in connection with this, the Company will be equipped to realize its growth ambitions and to further improve its position within medical treatments, both in the Nordic markets and internationally“, says Urban Jansson, Chairman of the Board of Directors of GHP.
GHP in brief
GHP’s focus is to provide highly specialised healthcare services in a limited number of selected treatment areas (Service Lines) and to become a leading company on a global basis in these. GHP has the ambition to...